Sanofi-Aventis Invests $65M in Cambridge, Massachusetts Growth
"We believe that Cambridge is really the heart of oncology today,'' Hanspeter Spek, president of Sanofi-Aventis global operations, said in a company conference call this year. "We intend to benefit from this environment as a neighbor.''
Massachusetts is banking on the pharmaceutical industry to buoy the state's economy. Two years ago Governor Deval Patrick began a $1 billion, 10-year plan to offer tax incentives to life sciences companies. Last year, 26 companies received a total of $24.5 million.
Sanofi-Aventis has applied for $2.45 million in state tax credits from the Life Sciences Center, and will ask for another $6.5 million over the next four years.
Several other foreign pharmaceutical companies have facilities around Boston, such as Novartis, Merck, GlaxoSmithKline, and AstraZeneca.
Supply Chain Bottlenecks Creating New “Logistical Hotspots”
2020 Top States for Doing Business Showcase Their Pro-Business Environments
2021 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Latest Trends in the Industrial Real Estate Sector Here to Stay
35th Annual Corporate Survey: Effects of Global Pandemic Reflected in Executives’ Site and Facility Plans
Auto Industry Is Betting on Sustainability
2021 Auto/Aero Site Guide